Cost-Effectiveness of Lenalidomide-Plus-Dexamethasone in Multiple Myeloma Patients Who Have Received at Least One Prior Therapy: A South Korean Perspective.

B Vandewalle,J Almeida,R Yeo,A Valeska,J Félix

doi:10.1016/j.jval.2014.08.111

Cost-Effectiveness of Lenalidomide-Plus-Dexamethasone in Multiple Myeloma Patients Who Have Received at Least One Prior Therapy: A South Korean Perspective.

B Vandewalle, J Almeida + Show 3 more

Open Access

https://doi.org/10.1016/j.jval.2014.08.111

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research	Publication Date: Oct 26, 2014
Citations: 3	License type: publisher-specific-oa

#South Korean Perspective #Multiple Myeloma Patients + Show 5 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Cost-Effectiveness of Lenalidomide-Plus-Dexamethasone in Multiple Myeloma Patients Who Have Received at Least One Prior Therapy: A South Korean Perspective.

Full Text